<i>BRAF/NRAS</i> Mutation Frequencies Among Primary Tumors and Metastases in Patients With MelanomaMaria Colombino, Giuseppe Palmieri, Antonella Manca et al.|Journal of Clinical Oncology|2012Cited by 460
Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathwaysFrancesca Bruzzese, Alfredo Budillon, Biagio Pucci et al.|Cell Death and Disease|2013Cited by 57
Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylaseElena Di Gennaro, Alfredo Budillon, Geny Piro et al.|British Journal of Cancer|2010Cited by 49
Cross‐linked hyaluronic acid filler hydrolysis with hyaluronidase: Different settings to reproduce different clinical scenariosRaffaele Rauso, Gianpaolo Tartaro, Nicola Zerbinati et al.|Dermatologic Therapy|2020Cited by 31
Immune cell infiltration and inflammatory landscape in primary brain tumoursAmalia Luce, Michele Caraglia, Marianna Abate et al.|Journal of Translational Medicine|2024Cited by 13